Omalizumab for Lupus

NCT01716312 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

NIH

Sponsor class

Conditions

Systemic Lupus Erthematosus
Sjogren's Syndrome

Interventions

DRUG: Omalizumab

Sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)